Search

Your search keyword '"Gong, Yixuan"' showing total 180 results

Search Constraints

Start Over You searched for: Author "Gong, Yixuan" Remove constraint Author: "Gong, Yixuan" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
180 results on '"Gong, Yixuan"'

Search Results

11. Supplementary Text from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

12. Supplementary Data 2 from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade

13. Supplementary Table S3 from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

14. Supplementary Tables S1 and S2 from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

15. Supplementary Figures 1-7 from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

16. Data from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade

17. Data from Reduced NF1 Expression Confers Resistance to EGFR Inhibition in Lung Cancer

18. Supplementary Data 1 from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade

19. Supplementary Figures from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade

20. Supplementary Data 3 from Prostate Cancer in World Trade Center Responders Demonstrates Evidence of an Inflammatory Cascade

21. Data from Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

22. Supplementary Materials and Methods from Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

23. Supplementary Methods and Figure Legends from Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors

24. STR DNA Profiling for Cell Line Authentication from Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

25. Supplemental Tables S1-S19. from Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

26. Figure S1-S5. from Small-Molecule Activators of Protein Phosphatase 2A for the Treatment of Castration-Resistant Prostate Cancer

27. Supplementary Figures 1-3 from Novel D761Y and Common Secondary T790M Mutations in Epidermal Growth Factor Receptor–Mutant Lung Adenocarcinomas with Acquired Resistance to Kinase Inhibitors

28. Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation

29. Inhibition of Pathologic Immunoglobulin E In Food Allergy by EBF2 and Active Compound Berberine Associated with Immunometabolism Regulation

33. In situ crystal engineering on 3D-printed woodpile scaffolds: a monolith catalyst with highly accessible active sites for enhanced catalytic cracking.

34. EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

39. Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases

40. Ultra-thin Two-Dimensional Trimetallic Metal–Organic Framework for Photocatalytic Reduction of CO2

44. Dual targeting of EGFR can overcome a major drug resistance mutation in mouse models of EGFR mutant lung cancer

45. Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas

50. Fibroblast Growth Factor Receptor 3 Alterations and Response to PD-1/PD-L1 Blockade in Patients with Metastatic Urothelial Cancer

Catalog

Books, media, physical & digital resources